论文部分内容阅读
目的:分析内镜治疗急性非静脉曲张性上消化道出血(ANVUGIB)的疗效。方法:选择汕头市中心医院2014年5月至2016年10月收治的60例ANVUGIB病患进行研究,随机分成治疗组与常规组各30例。常规组为常规止血,治疗组在此基础上给予内镜治疗,比较两组止血效果、再出血率、止血与住院时间。结果:(1)止血成功率:治疗组为96.67%,常规组为86.67%,组间比较,差异具有统计学意义(P<0.05);(2)治疗组的住院、止血时间比常规组短,差异具有统计学意义(P<0.05);(3)再出血率:治疗组为3.33%,常规组为13.33%,组间比较,差异具有统计学意义(P<0.05)。结论:ANVUGIB患者经内镜治疗,能缩短止血以及住院时间,降低再出血风险,疗效迅速、确切,应作为治疗ANVUGIB的首选方法。
Objective: To analyze the efficacy of endoscopic treatment of acute non-variceal upper gastrointestinal hemorrhage (ANVUGIB). Methods: Sixty ANVUGIB patients who were admitted to Shantou Central Hospital from May 2014 to October 2016 were selected and randomly divided into treatment group and control group, with 30 cases each. The conventional group was given conventional hemostasis. The treatment group was given endoscopic treatment on this basis. The hemostatic effect, rebleeding rate, hemostasis and hospital stay were compared between the two groups. Results: (1) The success rate of hemostasis was 96.67% in the treatment group and 86.67% in the conventional group. There was significant difference between the two groups (P <0.05). (2) The duration of hospitalization and stopping bleeding in the treatment group was shorter than that in the conventional group (P <0.05). (3) The rate of rebleeding was 3.33% in the treatment group and 13.33% in the conventional group. The difference between the two groups was statistically significant (P <0.05). Conclusions: Endoscopic treatment of ANVUGIB patients can shorten the time of hemostasis and hospital stay, reduce the risk of rebleeding, and has rapid and definite curative effect. It should be the first choice for the treatment of ANVUGIB.